ZIAD MUSAITIF: Open Payments
NPI 1316909328 · PEORIA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 22 payments from 10 companies in 2025. Trend: 2023 $17 · 2024 $104 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $146 |
| Alkermes, Inc. | 2 | $132 |
| Gilead Sciences, Inc. | 5 | $102 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $98 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Abbott Laboratories | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: INGREZZA, LYBALVI, CAPLYTA, REXULTI, COBENFY, VAXELIS, INVEGA SUSTENNA, FREESTYLE LIBRE 3.
Industry payments across IL — which companies pay providers there.
